28 May 2025 07:30 BRAIN Biotech AG reports final half-year figures for fiscal year 2024/25

20 May 2025 10:00 BRAIN Biotech announces buy-out of minorities, new continental European production site, and expansion of its Baking Application Center

18 March 2025 16:45 Results of the 2025 Annual General Meeting for the 2023/24 financial year of BRAIN Biotech AG

26 February 2025 07:30 BRAIN Biotech AG: 3M FY 24/25 - Starting the year with double digit sales growth in the core BRAINBiocatalysts division

13 February 2025 09:14 Biological gold recycling: BRAIN Biotech AG collaborates with PX Group on the PX Urban Mining Initiative

15 January 2025 07:30 Annual Report 2023/24: BRAIN Biotech AG acts from a strong cash position and is confident about its growth prospects

12 December 2024 09:00 BRAIN Biotech AG Sharpens Focus on Profitable Growth

31 October 2024 19:20 BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology

03 October 2024 14:00 Prof. Dr. Wiltrud Treffenfeldt leaves Supervisory Board of BRAIN Biotech AG for personal reasons

20 September 2024 19:50 BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator

29 August 2024 07:30 BRAIN Biotech AG presents strong cash position with its 9M reporting and is forecasting good sequential growth in the final quarter of the business year

29 May 2024 09:00 BRAIN Biotech AG announces the appointment of Erik de Vries as Senior Business Development Director Enzymes

28 May 2024 07:30 BRAIN Biotech AG receives major milestone payment and stays on-track to achieve year end targets 

16 April 2024 11:20 BRAIN Biotech AG takes next step to optimize group structure

14 March 2024 09:00 Beverages made from vine leaves: Sustainable drinking pleasure based on agricultural side streams

12 March 2024 17:17 Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG

05 March 2024 08:00 Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials

29 February 2024 20:40 BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives

28 February 2024 07:30 3M FY 23/24:  BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24

17 January 2024 07:30 Annual Report 2022/23: BRAIN Biotech AG successfully executes growth strategy

20 November 2023 09:44 Akribion Genomics receives the Hessian Founder Award for its innovative approach to a new cancer therapy

28 September 2023 10:30 BRAIN Biotech AG: BRAIN Biotech AG´s Akribion Genomics team wins first prize at the “BioRiver Boost!” startup competition

14 September 2023 10:30 BRAIN Biotech AG: BRAIN Biotech AG’s Akribion Genomics technology receives patent approval for its groundbreaking nuclease G-dase E®

12 September 2023 15:45 BRAIN Biotech AG: Scientist from BRAIN Biotech AG receives VAAM Innovation Award for the discovery of a novel CRISPR nuclease family

30 August 2023 07:30 BRAIN Biotech AG reports solid 9M numbers despite ongoing high R&D investments and more challenging economic conditions

28 June 2023 13:00 BRAIN Biotech AG´s Akribion Genomics team successfully competes in Science4Life Venture Cup competition

19 June 2023 12:30 Anniversary of BRAIN Biotech AG: 30 years for a bio-based future

25 May 2023 07:30 BRAIN Biotech AG stays on solid growth path with H1 results and accelerates One-BioProducts strategy

24 May 2023 09:30 BRAIN Biotech AG gains full ownership of Biocatalysts Ltd and accelerates execution of its One-BioProducts Strategy

08 March 2023 17:20 Resolutions of the Annual General Meeting 2023 on the Financial Year 2021/2022 of BRAIN Biotech AG

27 February 2023 16:00 Capital Markets Day 2023: BRAIN Biotech AG to build an international multi-niche enzyme and food ingredients champion

27 February 2023 07:30 BRAIN Biotech AG with Strong Start into Fiscal Year 2022/23, 3M Reporting

22 February 2023 14:00 BRAIN Biotech and TransCode Therapeutics join forces to develop a CRISPR-derived technology platform for cancer treatment

16 January 2023 07:30 BRAIN Biotech AG reports record figures in fiscal year 2021/22 − despite challenging geopolitical environment

10 January 2023 12:15 BRAIN Biotech AG: BRAIN Group's Akribion Genomics business will prioritize the development of therapeutic applications within its CRISPR technology platform

09 January 2023 12:10 BRAIN Biotech AG: Key Leadership Appointments at BRAIN Biotech AG, Zwingenberg Site

17 November 2022 10:00 BRAIN Biotech AG: MP Beteiligungs-GmbH Increases Stake in BRAIN Biotech AG

25 October 2022 09:30 BRAIN Biotech and Bonumose collaborate on enzymes for the production of rare monosaccharides

27 September 2022 07:30 Change in the Executive Management Board of BRAIN Biotech AG, genome editing activities established under the Akribion Genomics brand

26 September 2022 17:20 BRAIN Biotech AG sells subsidiary L.A. Schmitt to a URI group company

29 August 2022 07:30 BRAIN Biotech AG: On Track to Reach Financial Year 2021/22 Targets, 9M Reporting

20 June 2022 08:00 BRAIN Biotech publishes first ESG and Sustainability Report

30 May 2022 09:00 BRAIN Biotech AG: Prof. Dr. Bernhard Hauer leaves Supervisory Board of BRAIN Biotech AG for personal reasons

30 May 2022 07:30 BRAIN Biotech AG: Ongoing Dynamic Sales Development and Rising Profitability, 6M Reporting

04 April 2022 10:40 BRAIN Biotech AG: Successful Genome Editing in Mammalian Cells with BRAIN-Metagenome-Cas (BMC), BRAIN-Engineered-Cas (BEC)

09 March 2022 16:00 BRAIN Biotech AG: Resolutions of the Annual General Meeting for the Fiscal Year 2020/2021 of BRAIN Biotech AG

23 February 2022 07:30 BRAIN Biotech AG: Very Dynamic Start into the Fiscal Year 2021/22, 3M Reporting

08 February 2022 08:15 BRAIN Biotech and Formo: Strategic partnership of European biotech experts for the production of animal-free milk protein

01 February 2022 17:45 BRAIN Group significantly expands its food enzyme business with the acquisition of Breatec B.V. and Comix business

17 January 2022 07:30 BRAIN Biotech AG publishes Annual Report for FY 2020/21

11 January 2022 18:50 BRAIN Biotech AG: BRAIN-Engineered-Cas (BEC) Considered a Patentable Technology

08 December 2021 15:00 BRAIN Biotech AG: Additional Genome Editing Nuclease: BRAIN-Metagenome-Cas 01 (BMC01)

03 November 2021 10:00 BRAIN Biotech AG: BRAIN and SAMS apply BEC gene-editing technology to Omega-3 Compounds from Marine Organisms

15 September 2021 21:51 BRAIN Biotech AG successfully placed new share capital for the financing of further growth initiatives

03 September 2021 14:00 Capital Markets Day BRAIN Biotech AG: Focus on BEC Technology and its Transformational Potential

01 September 2021 10:00 BRAIN Biotech AG: BRAIN appoints University of Leiden as partner for BEC-Enabled production strain development

30 August 2021 07:30 BRAIN Biotech AG 9M '20/'21 Results

28 July 2021 08:30 BRAIN Biotech AG: Sartorius and BRAIN jointly researching and adapting novel CRISPR Cas-nucleases

21 July 2021 07:30 BRAIN Biotech AG: Novel Genome Editing Tool: Filing of International Patent Application

15 July 2021 11:00 BRAIN Biotech AG: Additional CRISPR Genome Editing Nucleases Identified

08 June 2021 11:00 BRAIN Biotech AG: BRAIN actively supports the UN Global Compact

28 May 2021 07:30 BRAIN Biotech AG H1 '20/'21 Results

12 May 2021 16:30 BRAIN Biotech AG expands stake in successful enzyme producer Biocatalysts Ltd.

06 May 2021 18:00 BRAIN Biotech AG: Genome Editing Tool Developed by BRAIN

10 March 2021 18:11 B.R.A.I.N. Biotechnology Research And Information Network AG: Resolutions of the Annual General Meeting for the Fiscal Year 2019/2020 of BRAIN AG

26 February 2021 07:30 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG Q1 '20/'21 Results

14 January 2021 08:00 BRAIN AG publishes its Annual Report for the Financial Year 2019/20

13 January 2021 08:00 B.R.A.I.N. Biotechnology Research And Information Network AG: Roquette and BRAIN Group agree on production scale-up for protein sweetener

07 January 2021 08:00 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN Group expands its US products business with the successful acquisition of Biosun Biochemicals Inc.

15 October 2020 16:07 B.R.A.I.N. Biotechnology Research And Information Network AG: Two experts join the BRAIN AG Supervisory Board

31 August 2020 08:30 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN is pleased with its results for the first nine months of the 2019/20 financial year

07 July 2020 08:30 B.R.A.I.N. Biotechnology Research And Information Network AG: Change in the Management Board of BRAIN AG - Chief Business Officer Ludger Roedder is leaving the executive board with immediate effect

02 July 2020 08:40 B.R.A.I.N. AG purchases the outstanding 24.7% minority stake of WeissBioTech GmbH

05 March 2020 16:23 B.R.A.I.N. Biotechnology Research And Information Network AG: Annual General Meeting for Fiscal Year 2018/2019

28 February 2020 08:30 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG is starting the 2019/20 financial year with a successful quarter

12 December 2019 08:59 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG publishes preliminary results for the financial year 2018/19

30 August 2019 08:30 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG shares strong nine-month figures demonstrating growth in all areas

29 May 2019 08:30 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG achieves significant growth in the first half of the 2018/19 financial year

12 March 2019 08:30 B.R.A.I.N. Biotechnology Research And Information Network AG: Natural-based sweeteners and sweet taste enhancers - Global beverage company has joined the DOLCE program

24 January 2019 16:36 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG proposes Supervisory Board candidates for election at its Annual General Meeting

14 December 2018 09:00 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN achieves double-digit growth in total operating performance and revenues in the 2017/18 financial year

11 December 2018 08:50 B.R.A.I.N. Biotechnology Research And Information Network AG: Nature-based freshness and product stability - Global beverage company joins BRAIN's newly established FRESCO program for nature-based preservation ingredients

18 September 2018 08:59 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG announces strategic research collaboration with BluCon Biotech GmbH

31 August 2018 08:30 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG reports growth for the first nine months of the 2017/18 financial year

22 August 2018 08:34 B.R.A.I.N. Biotechnology Research And Information Network AG: Biological Wound Care - BRAIN AG announces the creation of SolasCure Ltd. to continue development of Aurase(R)

28 February 2018 08:29 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG starts the financial year 2017/18 with a weak first quarter

07 September 2017 19:30 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG wins new long-term oriented investor by way of a capital increase

02 August 2017 10:03 B.R.A.I.N. Biotechnology Research And Information Network AG: Natural Active Ingredients for Cosmetics - Successful conclusion of joint BRAIN AG and BASF SE research project

21 June 2017 10:00 B.R.A.I.N. Biotechnology Research And Information Network AG: Sustainably produced food ingredients - BRAIN AG and Roquette successfully complete research collaboration

31 May 2017 08:30 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN on growth track in the first half-year 2016/17

21 March 2017 08:30 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG expands patent protection for Aurase(R) enzyme for the treatment of chronic wounds

09 March 2017 18:41 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG successfully concludes first Annual General Meeting as a stock listed company

28 February 2017 08:30 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN shows stable start into fiscal year 2016/17

09 February 2017 11:04 B.R.A.I.N. Biotechnology Research And Information Network AG: Free Float of BRAIN share successfully increased

31 January 2017 14:30 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN proposes Supervisory Board candidates for election at its Annual General Meeting

19 December 2016 13:02 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN announces preliminary financials for fiscal year 2015/16

16 November 2016 08:30 B.R.A.I.N. Biotechnology Research And Information Network AG: Two major food categories have joined DOLCE

26 September 2016 08:30 BRAIN AG appoints experienced corporate finance specialist to the Board of Management

31 August 2016 08:00 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN shows stable business performance in the first nine months 2015/16

29 August 2016 08:30 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN, AnalytiCon and Roquette sign a strategic partnership for the development of next generation natural sweetening solutions

31 May 2016 08:00 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN continues to demonstrate a solid business performance in the first half year 2015/16

10 March 2016 11:00 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN IPO: End of the stabilisation period and exercise of the Greenshoe Option

01 March 2016 12:10 B.R.A.I.N. Biotechnology Research And Information Network AG: NatLifE 2020 Strategic Alliance Given Go-Ahead After Successful Interim Review

20 January 2016 21:00 BRAIN AG sets IPO price range

05 January 2016 08:00 BRAIN AG announces Intention to Float